{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:48:26Z","timestamp":1759063706901},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1097\/mjt.0b013e3180a7206e","type":"journal-article","created":{"date-parts":[[2007,9,20]],"date-time":"2007-09-20T07:02:37Z","timestamp":1190271757000},"page":"462-468","source":"Crossref","is-referenced-by-count":8,"title":["In Vivo Prophylactic Activity of QR-435 Against H3N2 Influenza Virus Infection"],"prefix":"10.1097","volume":"14","author":[{"given":"John S","family":"Oxford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Lambkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Guralnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A","family":"Rosenbloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P","family":"Petteruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"DiGian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"LeFante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0001-706X(02)00050-5","article-title":"Avian influenza and human health.","volume":"83","author":"Capua","year":"2002","journal-title":"Acta Trop"},{"key":"R2-12-20210202","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3201\/eid1201.051254","article-title":"Influenza pandemics of the 20th century.","volume":"12","author":"Kilbourne","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R3-12-20210202","first-page":"43","article-title":"Influenza in the older adult. Indications for the use of vaccine and antiviral therapy.","volume":"56","author":"Sandhu","year":"2001","journal-title":"Geriatrics"},{"key":"R4-12-20210202","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3201\/eid1201.050826","article-title":"Influenza-associated deaths in tropical Singapore.","volume":"12","author":"Chow","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R5-12-20210202","first-page":"421","article-title":"Influenza: prospect for prevention and control.","volume":"18","author":"Williams","year":"2002","journal-title":"Kaohsiung J Med Sci"},{"key":"R6-12-20210202","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1371\/journal.pmed.0030212","article-title":"Delaying the international spread of pandemic influenza.","volume":"3","author":"Cooper","year":"2006","journal-title":"PLoS Med"},{"key":"R7-12-20210202","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1098\/rstb.2001.1008","article-title":"Influenza diagnosis and treatment: a view from clinical practice.","volume":"356","author":"Fleming","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R8-12-20210202","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review.","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"key":"R9-12-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1079\/AHR2005101","article-title":"Avian influenza virus: prospects for prevention and control by vaccination.","volume":"6","author":"Lee","year":"2005","journal-title":"Anim Health Res Rev"},{"key":"R10-12-20210202","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1086\/502326","article-title":"Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults.","volume":"25","author":"McGeer","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R11-12-20210202","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2165\/00019053-200523110-00003","article-title":"Antiviral agents for influenza: a comparison of cost-effectiveness data.","volume":"23","author":"Lynd","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"R12-12-20210202","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00151829-200504020-00004","article-title":"Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance.","volume":"4","author":"McKimm-Breschkin","year":"2005","journal-title":"Treat Respir Med"},{"key":"R13-12-20210202","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study.","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"R14-12-20210202","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1142\/S0192415X05002965","article-title":"Using herbal medicine as a means of prevention experience during the SARS crisis.","volume":"33","author":"Lau","year":"2005","journal-title":"Am J Chin Med"},{"key":"R15-12-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/acm.2005.11.49","article-title":"The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study.","volume":"11","author":"Lau","year":"2005","journal-title":"J Altern Complement Med"},{"key":"R16-12-20210202","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1348-0421.2002.tb02724.x","article-title":"Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells.","volume":"46","author":"Imanishi","year":"2002","journal-title":"Microbiol Immunol"},{"key":"R17-12-20210202","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/1.suppl_4.43","article-title":"Animal models for evaluation of compounds against influenza viruses.","volume":"1","author":"Boyd","year":"1975","journal-title":"J Antimicrob Chemother"},{"key":"R18-12-20210202","first-page":"55","article-title":"Induction and relief of nasal congestion in ferrets infected with influenza.","volume":"76","author":"Chen","year":"1995","journal-title":"Int J Exp Pathol"},{"key":"R19-12-20210202","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF01309867","article-title":"Pathogenicity of influenza A\/Seal\/Mass\/1\/80 virus mutants for mammalian species.","volume":"140","author":"Scheiblauer","year":"1995","journal-title":"Arch Virol"},{"key":"R20-12-20210202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/MR.44.2.303-330.1980","article-title":"Pathogenicity of influenza virus.","volume":"44","author":"Sweet","year":"1980","journal-title":"Microbiol Rev"},{"key":"R21-12-20210202","first-page":"444","article-title":"The relation of pyrexia and nasal inflammatory response to virus levels in nasal washings of ferrets infected with influenza viruses of differing virulence.","volume":"58","author":"Toms","year":"1977","journal-title":"Br J Exp Pathol"},{"key":"R22-12-20210202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/0264-410X(94)90071-X","article-title":"Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin.","volume":"12","author":"Webster","year":"1994","journal-title":"Vaccine"},{"key":"R23-12-20210202","first-page":"297","article-title":"Immunity to influenza in ferrets. XIV: comparative immunity following infection or immunization with live or inactivated vaccine.","volume":"62","author":"Fenton","year":"1981","journal-title":"Br J Exp Pathol"},{"key":"R24-12-20210202","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0166-3542(02)00053-0","article-title":"The H274Y mutation in the influenza A\/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.","volume":"55","author":"Ives","year":"2002","journal-title":"Antiviral Res"},{"key":"R25-12-20210202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-3542(01)00215-7","article-title":"Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo.","volume":"54","author":"Carr","year":"2002","journal-title":"Antiviral Res"},{"key":"R26-12-20210202","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1016\/j.vaccine.2003.10.054","article-title":"Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine.","volume":"22","author":"Lambkin","year":"2004","journal-title":"Vaccine"},{"key":"R27-12-20210202","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1016\/j.vaccine.2006.03.004","article-title":"Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to infection.","volume":"24","author":"Mann","year":"2006","journal-title":"Vaccine"},{"key":"R28-12-20210202","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/322801","article-title":"Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus.","volume":"184","author":"Herlocher","year":"2001","journal-title":"J Infect Dis"},{"key":"R29-12-20210202","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0166-3542(01)00214-5","article-title":"Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets.","volume":"54","author":"Herlocher","year":"2002","journal-title":"Antiviral Res"},{"key":"R30-12-20210202","first-page":"37","article-title":"Experience with oseltamivir in the control of a nursing home influenza B outbreak.","volume":"27","author":"Parker","year":"2001","journal-title":"Can Commun Dis Rep"},{"key":"R31-12-20210202","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.285.6.748","article-title":"Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.","volume":"285","author":"Welliver","year":"2001","journal-title":"JAMA"},{"key":"R32-12-20210202","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.","volume":"282","author":"Hayden","year":"1999","journal-title":"JAMA"},{"key":"R33-12-20210202","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/10408399709527797","article-title":"The chemistry of tea flavonoids.","volume":"37","author":"Balentine","year":"1997","journal-title":"Crit Rev Food Sci Nutr"},{"key":"R34-12-20210202","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","article-title":"Antiviral effect of catechins in green tea on influenza virus.","volume":"68","author":"Song","year":"2005","journal-title":"Antiviral Res"},{"key":"R35-12-20210202","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/095632020201300403","article-title":"Antiviral properties of prodelphinidin B-2 3-O-gallate from green tea leaf.","volume":"13","author":"Cheng","year":"2002","journal-title":"Antivir Chem Chemother"},{"key":"R36-12-20210202","first-page":"95","article-title":"The effect of an aqueous horse-radish extract, applied as such or in association with caffeine, on experimental influenza in mice.","volume":"36","author":"Esanu","year":"1985","journal-title":"Virologie"},{"key":"R37-12-20210202","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1183\/09031936.01.00084301","article-title":"Influenza: vaccination and treatment.","volume":"17","author":"Stephenson","year":"2001","journal-title":"Eur Respir J"},{"key":"R38-12-20210202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00430-002-0145-y","article-title":"Conceptional considerations for a German influenza pandemic preparedness plan.","volume":"191","author":"Fock","year":"2002","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"R39-12-20210202","first-page":"189","article-title":"Human infection by avian influenza A H5N1.","volume":"11","author":"Yuen","year":"2005","journal-title":"Hong Kong Med J"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e3180a7206e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:34:03Z","timestamp":1620963243000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-200709000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3180a7206e","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}